Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.20
Delayed Data
As of 4:00pm ET
 -0.09 / -2.74%
Today’s Change
2.58
Today|||52-Week Range
6.83
-9.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Operating ActivitiesNet Income / Starting Line84.5M78.3M69.5M100.6M
 
 
 
 
 
Total Other Cash Flow-6.8M-8.8M6.9M-49.0M
 
 
 
 
 
Funds From Operations81.1M74.4M77.1M59.7M
 
 
 
 
 
Funds From/For Other Operating Expenses9.2M-9.6M1.6M-10.4M
 
 
 
 
 
Net Cash Flow - Operating Activities71.8M84.1M75.5M70.1M
 
 
 
 
 
 
InvestingDecrease In Investments0.000.001.1M823.0K
 
 
 
Capital Expenditures0.000.00-9.0K0.00
 
 
Other Investing - Uses0.00-5.2M-3.8M-26.3M
 
 
 
 
Other Investing - Sources938.0K1.2M27.5M39.1M
 
 
 
 
 
Net Cash Flow Investing938.0K-4.1M-90.2M13.6M
 
 
 
 
 
 
FinancingShort Term Borrowings100.0M-25.0M-25.0M-25.0M
 
 
 
 
 
Long Term Borrowings-607.0K0.000.000.00
 
 
Long Term Debt Reduction-22.3M-155.1M0.00-43.0M
 
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-24.5M-24.5M-24.5M-24.7M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing52.5M-204.6M-49.5M-92.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash125.3M-124.6M-64.2M-9.0M